Average Co-Inventor Count = 7.46
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (20 from 124 patents)
2. Valo Early Discovery, Inc. (5 from 15 patents)
3. Valo Health, Inc. (3 from 29 patents)
4. Wyeth (1 from 1,309 patents)
29 patents:
1. 12043623 - Purinones as ubiquitin-specific protease 1 inhibitors
2. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
3. 11795171 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
4. 11739071 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
5. 11161848 - Purinones as ubiquitin-specific protease 1 inhibitors
6. 10981915 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
7. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
8. 10927130 - Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
9. 10906916 - Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
10. 10836741 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
11. 10519127 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
12. 10519128 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
13. 10519129 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
14. 10519130 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
15. 10513507 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors